AGP Picks
View all

The Africa Gazette
Provided by AGP

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 4, 2026

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
May 4, 2026

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

Indeterminate GlobeNewswire
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
May 4, 2026

CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society
May 4, 2026

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Indeterminate GlobeNewswire
Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer
May 4, 2026

Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer

Indeterminate GlobeNewswire
Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
May 4, 2026

Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
May 4, 2026

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

Indeterminate GlobeNewswire
Panoro Announces Brokered LIFE Offering for Gross Proceeds of up to $20 Million
May 4, 2026

Panoro Announces Brokered LIFE Offering for Gross Proceeds of up to $20 Million

Indeterminate GlobeNewswire
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
May 4, 2026

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

Indeterminate GlobeNewswire
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
May 4, 2026

BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026

Indeterminate GlobeNewswire
Dynacor Group Receives TSX Approval To Renew Normal Course Issuer Bid
May 4, 2026

Dynacor Group Receives TSX Approval To Renew Normal Course Issuer Bid

Indeterminate GlobeNewswire
Groupe Dynacor : TSX approuve la poursuite de l’offre publique de rachat d’actions dans le cours normal des activités
May 4, 2026

Groupe Dynacor : TSX approuve la poursuite de l’offre publique de rachat d’actions dans le cours normal des activités

Indeterminate GlobeNewswire
DEEP SEA MINERALS CORP. PARTICIPATES IN EXIM BANK’S 2026 ANNUAL CONFERENCE IN WASHINGTON, DC
May 4, 2026

DEEP SEA MINERALS CORP. PARTICIPATES IN EXIM BANK’S 2026 ANNUAL CONFERENCE IN WASHINGTON, DC

Indeterminate GlobeNewswire
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
May 4, 2026

InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes

Indeterminate GlobeNewswire
Discovery Announces Details of First Quarter 2026 Results Conference Call and Webcast
May 4, 2026

Discovery Announces Details of First Quarter 2026 Results Conference Call and Webcast

Indeterminate GlobeNewswire
Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential
May 4, 2026

Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential

Indeterminate GlobeNewswire
Forte Minerals Graduates to OTCQX® Best Market
May 4, 2026

Forte Minerals Graduates to OTCQX® Best Market

Indeterminate GlobeNewswire
Indivior Announces $175 Million Accelerated Share Repurchase
May 4, 2026

Indivior Announces $175 Million Accelerated Share Repurchase

Indeterminate GlobeNewswire
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
May 4, 2026

BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema

Indeterminate GlobeNewswire
GFG Significantly Expands Goldarm Property Following Encouraging Regional Exploration Results in the Timmins Gold District
May 4, 2026

GFG Significantly Expands Goldarm Property Following Encouraging Regional Exploration Results in the Timmins Gold District

Indeterminate GlobeNewswire
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
May 4, 2026

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Africa Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.